Previous Article | Next Article 
Journal of Virology, May 1999, p. 4350-4359, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Retrograde, Transneuronal Spread of Pseudorabies Virus in Defined
Neuronal Circuitry of the Rat Brain Is Facilitated by gE Mutations
That Reduce Virulence
M.
Yang,1
J.
P.
Card,2
R. S.
Tirabassi,3
R. R.
Miselis,1 and
L.
W.
Enquist3,*
Department of Animal Biology, University of
Pennsylvania Veterinary School, Philadelphia, Pennsylvania
191041; Department of Neuroscience,
University of Pittsburgh, Pittsburgh, Pennsylvania
152602; and Department of Molecular
Biology, Princeton University, Princeton, New Jersey
085443
Received 9 November 1998/Accepted 11 February 1999
 |
ABSTRACT |
The pseudorabies virus (PRV) gE gene encodes a multifunctional
membrane protein found in infected cell membranes and in the virion
envelope. Deletion of the gE gene results in marked attenuation of the
virus in almost every animal species tested that is permissive for PRV.
A common inference is that gE mutants are less virulent because they
have reduced ability to spread from cell to cell; e.g., gE mutants
infect fewer cells and, accordingly, animals live longer. In this
report, we demonstrate that this inference does not hold in a rat
experimental model for virus invasion of the brain. We find that
animals infected with gE mutants live longer despite extensive
retrograde, transneuronal spread of virus in the rat brain. In this
model of brain infection, virus is injected into the stomach
musculature and virions spread to the brain in long axons of brain stem
neurons that give rise to the tenth cranial nerve (the vagus). The
infection then spreads from neuron to neuron in well-defined, and
physically separated, areas of the brain involved in autonomic
regulation of the viscera. We examined the progression of infection of
five PRV strains in this circuitry: the wild-type PRV-Becker strain,
the attenuated PRV-Bartha vaccine strain, and three gE mutants isogenic
with the PRV-Becker strain. By 60 to 67 h after infection, all
PRV-Becker-infected animals were dead. Analysis of Becker-infected rats
killed prior to virus-induced death demonstrated that the virus had
established an infection only in the primary vagal neurons
connected directly to the stomach and synaptically linked neurons in
the immediate vicinity of the caudal brain stem. There was little
spread to other neurons in the vagus circuitry. In contrast, rats
infected with PRV-Bartha or PRV-Becker gE mutants survived to
at least 96 h and exhibited few overt signs of disease. Despite
this long survival and the lack of symptoms, brains of animals
sacrificed at this time revealed extensive transsynaptic
infection not only of the brain stem but also of areas of the forebrain
synaptically linked to neurons in the brain stem. This finding provides
evidence that the gE protein plays a role in promoting symptoms
of infection and death in animals that is independent of
neuron-to-neuron spread during brain infection. When this early
virulence function is not active, animals live longer, resulting in
more extensive spread of virus in the brain.
 |
INTRODUCTION |
Alphaherpesviruses can infect the
central nervous system (CNS) by invading neurons in the periphery and
then replicating and spreading to the CNS through synaptically linked
neurons. This ability to pass transsynaptically has led to the
increasing use of these viruses for analysis of neuronal circuitry
(8, 18, 29, 35, 44, 47). The attenuated pseudorabies
virus (PRV) vaccine strain called Bartha is widely used for this
purpose (5). Although the reduced virulence of this strain
contributes to its usefulness for circuit analysis, we do not have a
clear understanding of the genetic basis that underlies its efficient
neuroinvasiveness (ability to infect the CNS). Several mutations in the
PRV-Bartha genome have been characterized. For example, a
deletion in the unique short region of the genome removes sequences
coding for gI, gE, Us9, and Us2 (30, 31). Additionally, the
gC gene in the unique long (UL) region harbors several mutations,
including one in the signal sequence that reduces the concentration of
gC in the viral envelope and in host cell membranes (42).
There are eight nucleotide point mutations in the BglII-B
and BamHI-4 segments of PRV-Bartha (23, 24, 32).
Three of these mutations result in amino acid substitutions in the UL21
protein which is involved in capsid formation (14).
Recently, Mettenleiter and colleagues found that PRV-Bartha carries two
mutations in the gM gene, which result in a threonine-to-alanine change
at amino acid position 59, eliminating an N-linked glycosylation
signal, and a serine-to-proline substitution at position 60, which
could potentially affect the secondary structure of the protein
(15). The PRV-Bartha strain grows exceedingly well in most
tissue culture cells, is more stable to temperature extremes than
wild-type strains, and also is much less pathogenic than field
isolates. Nevertheless, PRV-Bartha is still capable of efficient and
extensive transneuronal, retrograde spread through the nervous systems
of a wide variety of animals (18).
Of all the defects in the Bartha strain, the loss of membrane proteins
gE and gI has demonstrable effects on virulence and spread in the
nervous system (20). Homologous proteins of PRV gE and gI
are found in all other members of the alphaherpesvirus subfamily (e.g.,
herpes simplex virus type 1, varicella-zoster virus, bovine herpesvirus
1, and equine herpesvirus 1), suggesting conserved biological function
(34). While the PRV gE and gI gene products are not required
for virus replication in tissue culture, null mutants display modest
defects in viral release from certain cells and reduced spread from
cell to cell as evidenced by smaller plaque size compared to those
produced by wild-type virus (6, 22, 36, 37, 49, 51).
Deletions or mutations of either gE or gI reduce virulence in chicken
embryos, 1-day-old chicks, mice, and pigs (1, 4, 21, 22, 25,
38). In addition, analysis of PRV invasiveness of visual centers
after retina infection in the rat has demonstrated that gE and gI
mutants exhibit a restricted neurotropism relative to that of wild-type virus (48). Other studies of PRV have shown that gE may be
involved in viral tropism for the thymus (25).
Interestingly, PRV gE null mutants appeared to acquire tropism for the
liver, an organ not infected by wild-type virus. Herpes simplex virus
type 1 deletion mutants lacking gE or gI have also been shown to have
restricted cell-to-cell spread in vitro, restricted rate of spread
within the retina and to retinorecipient areas in the rat brain, and reduced pathogenesis in a mouse eye infection model (16,
17), as well as attenuated neurovirulence and neuroinvasiveness
in mice (3, 40). Varicella-zoster virus mutants lacking gE
show significant restriction in cell-to-cell spread and reduced yield of infectious virus (33). Collectively, these findings
provide strong evidence that the gE and gI proteins play important
roles in determining the extents of cell-to-cell spread,
invasiveness, and virulence of alphaherpesviruses.
Given that PRV-Bartha is an attenuated strain, it may appear
counterintuitive that in most animals, this strain is far more neuroinvasive than virulent field strains of the virus (11). Indeed, PRV-Bartha infects the CNS of a wide variety of
animals after peripheral inoculation and consistently spreads by
transsynaptic infection to more second- and third-order neurons than do
virulent strains of PRV (18). This observation challenges
the idea that virulence is directly related to the magnitude of
neuroinvasiveness (e.g., the number of CNS neurons that are infected)
and suggests that viral gene products other than those responsible for
virus invasion and spread are responsible for the early demise of
infected animals. In this report we provide direct evidence that
PRV mutants with point mutations and deletions of the gE gene do not
express an early virulence function, with the result that animals
infected with these mutants survive longer than those infected with
their isogenic parent. This longer survival facilitates
widespread, retrograde, transsynaptic infections of the rat CNS
that are far more extensive than those produced by the virulent
parental virus.
 |
MATERIALS AND METHODS |
Model system: the neuronal circuitry innervating stomach
muscles.
The experiments were conducted using the stomach muscle
infection model developed by Card and colleagues (11) and
illustrated in Fig. 1. Injection of PRV
into stomach muscles produces a retrograde infection of neurons in
autonomic cell groups of the spinal cord and brain stem, followed by
continued retrograde infection of synaptically linked neurons in other
regions of the brain involved in regulating activity of the stomach
muscles and other visceral organs. A retrograde infection is defined as
spread of virus from the axon terminals to the parent neurons; the
direction of retrograde spread of virus is opposite to that of the
nerve impulse. We have previously used this well-defined circuitry to
verify the specificity and direction of transsynaptic passage of PRV,
as well as the brain's response to infection that contributes to that
specificity (10, 11, 41). Several areas of the brain were
used to gauge the progression of infection produced by the different
strains of virus. These included the dorsal motor vagal complex (DVC) and adjacent medulla in the caudal brain stem, as well as selected regions in the forebrain (paraventricular hypothalamic
nucleus, central nucleus of the amygdala [CeAm], bed nucleus of the
stria terminalis [BNST], subfornical organ [SFO], and insular
cortex). The location of each of these regions in the brain is
illustrated in Fig. 1. Other regions of the stomach circuitry are well
known and were infected by PRV in these studies, but are not
illustrated in this figure for simplicity of presentation and analysis.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 1.
The circuitry analyzed in the present study is
diagrammed schematically in a sagittal view of the rodent brain.
Retrograde, transsynaptic infection of the CNS by PRV can take place
via two pathways following injection of virus into stomach muscles.
Neurons from two subdivisions of the autonomic nervous system innervate
the stomach. Axon terminals provide sites of entry, and the axons
provide conduits for viral infection of the cell bodies of these
neurons in the brain stem. The most direct infection is achieved by
retrograde infection of caudal brain stem neurons in the DMV. However,
retrograde transsynaptic passage of virus through a disynaptic circuit
involving pseudounipolar neurons in the celiac ganglion also leads to
infection of sympathetic preganglionic neurons in the intermediolateral
cell group (IML) in the spinal cord. Retrograde transsynaptic passage
of virus from the DMV and IML produces an infection of other cell
groups in the brain stem and forebrain. The organization of this
circuitry is described in greater detail in the Materials and Methods
section. The lines labeled A, B, and C define the planes of section
used in subsequent illustrations. Abbreviations: AP, area postrema;
BNST, bed nucleus of stria terminalis; CeAm, central nucleus of the
amygdala; NTS, nucleus of the solitary tract; PT, paratrigeminal
nucleus; PVN, paraventricular hypothalmic nucleus; IC, insular cortex;
RF, reticular formation. The subfornical organ (SFO) lies in the
C-plane, just above the BNST.
|
|
The dorsal motor vagal complex (DVC) and adjacent medulla provide an
accurate index of early infection of the CNS. The DVC
consists of a
complex of three cell groups involved in the regulation
of visceral
function and, as such, has direct connections with
the stomach. Neurons
in the dorsal motor vagal nucleus (DMV) give
rise to axons that project
through the vagus nerve (cranial nerve
X) to the stomach, where they
synapse upon neurons that control
the contractility of stomach
musculature and gastric secretions.
These DMV neurons are the first
neurons in the brain to be infected.
Injection of virus into the
stomach wall leads to invasion of
the axons of DMV neurons and
ultimately, spread to and viral replication
in the cell bodies of these
neurons in the brain stem. The nucleus
of the solitary tract (NTS) lies
immediately above and adjacent
to the DMV and contains neurons that
synapse upon DMV neurons.
NTS neurons can be infected by retrograde
transsynaptic passage
of virus through DMV neurons. In addition, there
is some evidence
that certain strains of virus can infect NTS neurons
by transganglionic
infection through sensory fibers of the nodose
ganglion at long
postinoculation intervals (
10). The area
postrema (AP) is a
midline region lacking a blood-brain
barrier that lies immediately
adjacent to the NTS. AP neurons project
axons into the NTS and
can become infected via retrograde transsynaptic
passage of virus
from infected NTS neurons. Neurons in the DVC
generally exhibit
a progression of infection in which virus is seen
first in the
DMV, followed sequentially by infection of the NTS and the
AP.
Presence of viral antigen in these areas provides a precise and
reliable indication of early
infection.
Transsynaptic progression of infection can be monitored by the
subsequent appearance of viral antigen in two additional regions
of the
medulla that are in synaptic contact with the DVC. These
regions are
the paratrigeminal cell groups (PT) in the dorsolateral
portion of the
caudal brain stem and neurons in the reticular
formation at the ventral
and lateral extent of the medulla. The
locations of both regions are
shown in Fig.
2. Neurons in each
area
project axons into the DVC and they become infected after
viral antigen
appears in neurons of the DMV, NTS, and AP. Thus,
they provide added
temporal precision to determining the progression
of transsynaptic
passage of PRV through the neuronal circuitry
that regulates stomach
muscle activities.

View larger version (102K):
[in this window]
[in a new window]
|
FIG. 2.
Low-power photomicrographs illustrate the progression of
infection in the caudal brainstem 60, 72, and 96 h following
injection of strains of PRV. Negative images, where viral
immunoreactivity is revealed as a white signal on a dark background,
are shown. PRV-Becker (PRV-Be), a wild-type strain of PRV, infects a
large number of neurons in the DVC (DMV, NTS, and AP) 60 h
postinoculation, but only scattered neurons are infected in the
ventrolateral portion of the medulla. Animals infected by this virus
did not survive beyond 67 h in this study. Photomicrographs in
other rows illustrate the patterns of infection produced by PRV-91,
PRV-25, PRV-26, and PRV-Bartha (PRV-Ba). PRV-Ba, an attenuated vaccine
strain harboring a number of deletions and mutations, produces the
most-extensive infection at all postinoculation intervals. PRV-25,
PRV-26, and PRV-91 infect a subset of the circuitry infected by PRV-Ba,
but they still produce extensive retrograde infections. RF, reticular
formation.
|
|
Transneuronal spread can be documented further by analysis of several
areas in the forebrain that contain neurons projecting
axons to cell
groups in the DVC and spinal cord. These regions
also are infected by
injection of PRV into the stomach (Fig.
1).
Two of these areas, the
paraventricular nucleus (PVN) and bed
nucleus of the stria terminalis
(BNST), are among the areas of
the forebrain that are infected earliest
by retrograde transsynaptic
transport of PRV from the stomach. Three
other regions, the central
nucleus of the amygdala (CeAM), the
subfornical organ (SFO), and
insular cortex, become infected after
viral antigen is detected
in the PVN and BNST. The locations of all of
these areas in the
brain are shown in Fig.
1 and
3. The PVN, BNST, and CeAm have
direct
connections to the DVC, but the temporal differences in
the infection
of these two areas suggests that they have different
synaptic targets.
For example, the temporal separation in the
infection of these regions
suggests that axons of PVN and BNST
neurons synapse directly upon the
DMV neurons while those of the
CeAm synapse upon neurons of the NTS.
Such a synaptic arrangement
would require an extra round of viral
replication in NTS neurons
before retrograde transsynaptic infection of
CeAm neurons and
would thereby explain the delay of infection of this
cell group
relative to that of neurons in the PVN. The delayed
infection
of the SFO may occur because SFO neurons project to the PVN
but
do not have axons that extend to the caudal brain stem or spinal
cord (
2,
28,
39,
43). Thus, virus must first replicate
in
the PVN before passing transsynaptically to infect neurons
in the SFO.

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 3.
The extents of retrograde transsynaptic infection of the
forebrain produced by injection of PRV mutants into the wall of the
stomach are illustrated. Low-power, negative images, where
circumscribed areas of viral immunoreactivity are revealed as a white
signal on a dark background, are shown. Vertical columns illustrate
selected coronal-plane sections obtained at the levels of B (right
column) and C (left column) illustrated in Fig. 1. Horizontal rows
illustrate the pattern of infection produced by PRV-25, PRV-26, PRV-91,
and PRV-Bartha (PRV-Ba) 96 h following stomach inoculation.
Animals injected with PRV-Becker did not survive that long and could
not be analyzed. The most-extensive infection is produced by PRV-Ba.
The other mutants infect a subset of the neurons infected by PRV-Ba.
IC, insular cortex.
|
|
PRV strains.
Five strains of virus were used in this
analysis. PRV-Becker is a virulent laboratory strain that has been used
in prior characterizations of the invasiveness in this circuitry. It
was also the parent virus for three of the other strains: PRV-25,
PRV-26, and PRV-91. Construction of each of these mutants has been
described in reports about prior investigations (45, 46,
48). Briefly, PRV-91 is a null mutant that is isogenic with
PRV-Becker and lacks the gE gene. PRV-25 and PRV-26 are also isogenic
with PRV-Becker. PRV 25 contains an insertion of one base in the
sequences encoding the transmembrane domain of the protein
(45). Translation of this gene produces a protein containing
the wild-type N-terminal ectodomain of the protein fused to a novel
cytoplasmic tail. gE is anchored in the membranes of infected cells.
Functionally, this protein is equivalent to a gE protein lacking the
cytoplasmic tail. PRV-26 has a stop codon at amino acid 428 and
produces a form of the gE protein that lacks a transmembrane domain and
cytoplasmic tail. The N-terminal ectodomain of gE produced in cells
infected with this virus is secreted. PRV-Bartha is an attenuated
vaccine strain containing the mutations and deletions described in the introduction (5). It has also been used in prior studies of the invasiveness of PRV in this circuitry (41). The 50%
lethal doses (LD50) for wild-type PRV (Becker strain or
Kaplan strain) and PRV gE null mutants in mice and rats, about 50 to
100 PFU, are virtually identical (references 9 and
51 and our unpublished observations). The
LD50 in rats and mice for the attenuated Bartha strain is
about 100 times greater than that for the Becker strain (9).
In this study, we infected animals with the same numbers of PFU of all
viruses because our model system involves uptake of the inoculum at
axon terminals in the stomach followed by retrograde transport to the
cell bodies of neurons in the brain stem, where primary replication
occurs. Thus, we strove to infect the same number of primary neurons
with the same number of virions. The amount of virus we used was at
least 100-fold the LD50 to ensure that every animal became
infected and that there was an amount of virus in the primary neurons
sufficient to initiate a productive infection. As a result, every
animal should die and the mean time to death can be quantitated. This
parameter is highly characteristic of the genotype of the virus
(9, 46, 50).
Experimental paradigm.
Adult male Sprague-Dawley albino rats
were used in this study. Animals were housed in a biosafety level 2 facility with controlled temperature and photoperiod (12 h of light;
light on at 0700). Five groups of animals that differed only in the
strain of virus with which they were injected were included in the
analysis. Table 1 provides information on
the viruses, titers, times at which animals were euthanized after
infection, and numbers of animals included in each experimental group.
For the initial infections, each animal was anesthetized with ketamine
(60 mg/kg of body weight) and xylazine (7 mg/kg) and the stomach was
exposed after laparotomy. A total of 6 µl of virus was injected into
the ventral and dorsal muscular wall of the stomach with a 10-µl
Hamilton syringe equipped with a 26-gauge needle. Three injections,
e.g., one each into the antrum, fundus, and ruminal segments, were made
on each surface of the stomach wall to ensure efficient retrograde
infection of the DMV as described previously (10, 41).
Injection sites were swabbed with sterile saline, and the abdominal
wall was closed with suture and wound clips. Animals recovered under a
heat lamp and then were returned to their home cages for the balance of the experiment. Symptoms of infection were monitored throughout the
experiment. These included nasal discharge, hardarian gland discharge,
labored breathing, hunched posture, sensory irritation, and lethargy.
At approximately 60, 72, 84, 93 and 96 h after infection,
surviving animals were anesthetized and sacrificed by transcardiac
perfusion fixation with buffered aldehyde solutions by using published
procedures (
8,
44). The brains were removed, postfixed,
cryoprotected,
and sectioned serially in the coronal plane at 30-µm
section thickness
with a rotary microtome equipped with a freezing
stage. Sections
separated by distances of 180 µm (every sixth
section) were processed
for immunohistochemical localization of viral
antigens by using
rabbit polyclonal antiserum prepared against
acetone-inactivated
PRV and the avidin-biotin modification of the
immunoperoxidase
procedure (
8). This antibody detects the
viral capsid, tegument,
and membrane proteins in fixed, infected
tissue. Thus, any neuron
that reacts with the antiserum is producing
PRV structural proteins,
most of which require DNA replication for
synthesis. Processed
sections were mounted on gelatin-coated
slides, dehydrated, cleared,
and coverslipped. The aforementioned
regions were examined with
a light microscope, and the magnitude of
infection (number of
infected neurons) in serial sections made through
each region
was documented by photomicroscopy. In all cases, sections
covering
the entire brain and brain stem were examined. In Fig.
2 and
3 low-power, negative images of selected single sections, where
viral
immunoreactivity is revealed as a white signal on a dark
background,
are shown. The patterns of infected neurons extend
rostrally
and caudally for several sections, such that we can
outline the entire
caudal brain stem with precision. In Fig.
4 to
7, selected high-power,
positive images, where immunoreactivity
representing virus replication
in individual neurons is detected
as a black signal on a light
background, are shown. Experimental
protocols were approved by the
Animal Welfare Committees of the
University of Pennsylvania and
Princeton University and were consistent
with the regulations of the
American Association for Accreditation
of Laboratory Animal Care and
those in the Animal Welfare Act
(public law 99-198).
 |
RESULTS |
Our experiments produced two primary results. First, deletions or
mutations of gE substantially reduced the symptoms of viral infection
in the stomach model and resulted in extended survival of infected
animals relative to that of animals infected with wild-type virus.
Second, because of this longer survival, virus continued to spread
in the vagus circuitry, with the result that infected neurons were
found throughout most of the brain centers in this autonomic control
system. These centers were not infected by wild-type virus because of
early animal death.
gE mutants exhibit reduced virulence.
Rats infected with PRV
mutants harboring defined gE mutations exhibited a delay in the onset
of symptoms, a reduction in symptom severity, and extended survival
compared to rats infected by wild-type virus. In this study, no animals
infected with the virulent PRV-Becker strain survived longer than
67 h, and rats infected with this strain exhibited pronounced and
severe symptoms of infection as early as 48 h postinoculation.
Typically, these symptoms included a hunched posture, piloerection, and
lethargy. Infected rats were hyperresponsive to touch and
characteristically exhibited signs of sensory irritation. Secretions
from the mouth, nares, and eyes were evident by 50 h and were
pronounced by 60 h after infection. In addition,
PRV-Becker-infected animals lost approximately 20% of their
initial body weight during the experiment.
The effects of gE mutants upon the health of infected animals were
markedly different from those produced by PRV-Becker. Animals
infected
with PRV-Bartha routinely survived to 96 h postinoculation
and
exhibited only modest signs of infection that became apparent
in the
longest surviving animals. These animals showed no signs
of weight
loss, continued to groom, and remained quite active
before 72 h
postinoculation. The only overt sign of infection,
even at late times
after infection, was the appearance of secretions
at the corners of the
eyes as well as from the nares and mouth.
Extended survival and similar
mild symptoms were exhibited by
animals infected with PRV-91 (gE null
mutant). Similarly, animals
infected with PRV-25 and PRV-26 (both are
mutants that express
gE proteins lacking the cytoplasmic domain)
exhibited noticeable
reductions in virulence, but symptoms were more
varied from animal
to animal, more so than those observed after
infection with PRV-91
or PRV-Bartha (
46). We noted that
occasionally animals infected
with either PRV-25 or PRV-26 died
abruptly and unexpectedly at
approximately 72 h after infection
(e.g., they showed no signs
indicating death was imminent). However,
these animals were the
exception rather than the rule: 4 of a total of
12 PRV-25-infected
rats that developed infection died early, and 1 of a
total of
11 PRV-26 infected rats that developed infection died early.
Even
these early deaths occurred well beyond the time at which all
PRV-Becker-infected animals showed severe symptoms and had succumbed
to
infection.
Reduction in virulence of gE mutants did not correlate with
neuroinvasiveness.
The increased survival of animals infected with
the gE mutants resulted in extensive retrograde infection of neurons
synaptically linked with the autonomic neurons that project axons to
the stomach. This extensive spread is readily apparent in Fig. 2, which
illustrates the magnitudes of infection in one typical section through
the caudal brain stem produced by injection of equivalent
concentrations of the different strains of PRV. The longest surviving
PRV-Becker-infected animals (60 h) exhibited extensive infections of
the primary neurons in the DMV and second-order neurons in the NTS,
with only scattered infected neurons in the AP, the PT, and
ventrolateral medulla. Equivalent sections through the caudal brain
stem of animals infected with gE mutants sacrificed at 60 h
demonstrated that the magnitude of infection occasionally was reduced
relative to that produced by PRV-Becker, but the infection was still
extensive (see Fig. 4 for a close-up view). In all of the infections by
mutant viruses at this time point, the infection was largely confined
to the DVC, with only occasionally infected neurons in either the PT or
ventrolateral medulla being noted. Furthermore, the magnitude of
infection within the DVC was often equal to that observed in the same
area of PRV-Becker-infected animals (compare Fig. 2 and Fig.
4). The magnitude of infection in the
caudal brain stem by gE mutants increased progressively. Retrograde
transsynaptic passage of the gE mutants led to infection of neurons
throughout the DVC, including the AP, as well as infection of large
numbers of neurons in adjacent regions of the medulla (compare Fig. 2
and Fig. 4). By 72 h postinfection, the entire vagus complex in
the brain stem was infected, and this infection was more extensive than
that produced by PRV-Becker at 60 h, a time at which most
PRV-Becker-infected animals were dead or exhibited terminal symptoms.
PRV-Bartha-infected rats exhibited the most-extensive infections, with
the least-overt symptoms. In addition to the robust infection of the
DVC, these animals had large numbers of infected neurons in the
paratrigeminal complex and in the portion of the ventrolateral medulla
that contains brain stem catecholamine neurons. Infected neurons were
also present along the midline in the raphe nuclei. All of these areas
have documented synaptic connections with neurons in the DVC, and they became infected subsequent to the appearance of detectable viral antigen in that region.

View larger version (142K):
[in this window]
[in a new window]
|
FIG. 4.
High-power photomicrographs illustrate the extents of
infection in primary neurons of the DMV and synaptically connected
second-order neurons of the NTS 60 h after inoculation of the
stomach with different strains of PRV. Positive images, where viral
immunoreactivity in individual neurons is detected as a black signal on
a light background, are shown. The most-extensive infection is observed
in animals infected with PRV-Becker (Be), which also produces the
most-pronounced neuropathology, indicated by extensive cytopathic
effect. PRV-Bartha (Ba) also infects a large number of DMV and NTS
neurons at this time after inoculation, but both the extent of
infection and the degree of cytopathology are reduced relative to those
produced by PRV-Becker. PRV-25, PRV-26, and PRV-91 infect a subset of
the neurons infected by PRV-Ba. The schematic diagram in the lower
right corner illustrates the organization of synaptic connections
through which this circuitry is infected. CC, corpus callosum; XII,
12th cranial nerve. Calibration bar = 100 mm.
|
|
Infected forebrain neurons located some distance from the brain stem
became apparent as early as 66 h after inoculation, and
their
numbers increased thereafter. Again, the most-robust infection
was
observed in PRV-Bartha-infected rats that were sacrificed
96 h
after inoculation. These animals exhibited exceptionally
large numbers
of infected neurons in the PVN, CeAm, BNST, SFO,
and insular cortex
(Fig.
3). The same cell groups were infected
by gE mutants, but often
subsets of cells were infected (see the
following paragraph). An
example of the temporal progression of
infection is shown in Fig.
5
through
7,
which illustrate infected
neurons in the PVN 60, 72, and 96 h
postinoculation. This cell
group contains large numbers of
parvicellular neurons that participate
in the regulation of
autonomic function and are sequestered in
distinct subdivisions that
project to the brain stem and spinal
cord. The earliest
infection of PVN neurons was observed in the
medial parvicellular
subdivision of the nucleus (Fig.
5). With
advancing survival
time, the number of infected cells in the medial
parvicellular
subdivision increased and infected neurons also
became apparent
in the dorsal parvicellular subdivisions. Similar
patterns of
progression of infection were noted in other forebrain
nuclei.
The observation of the progression of infection in the
CeAm was
particularly informative from the standpoint of defining
the
temporal sequence of infection. This cell group has four distinct
subdivisions that are synaptically connected, but only the medial
subdivision projects to the DVC. Thus, early infections are restricted
to the medial subdivision whereas infections at longer
postinoculation
intervals characteristically exhibit infected neurons
throughout
all four subfields. This is evident in comparing the CeAm
infections
produced by PRV-26 and PRV-Bartha illustrated in Fig.
3.

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 5.
The distributions of infected neurons in the PVN
observed 60 h following inoculation of the stomach with PRV-Becker
(Be), PRV-91, PRV-25, PRV-26, and PRV-Bartha (Ba) are illustrated.
Positive images, where viral immunoreactivity in individual neurons is
detected as a black signal on a light background, are shown. PRV-Ba
produces the most-extensive infection of neurons in the medial
parvicellular subdivision of the PVN (mpPVN) that give rise to
descending projections to autonomic cell groups in the brain stem (DMV)
and spinal cord (IML). The schematic diagram in the lower right panel
illustrates the subdivisions of this hypothalamic nucleus that is
synaptically connected to the DMC in the brain stem. Other strains of
virus produce a more restricted pattern of infection. Calibration
bar = 200 mm. dpPVN, dorsal parvicellular subdivision of the PVN
(dpPVN).
|
|

View larger version (105K):
[in this window]
[in a new window]
|
FIG. 6.
The distributions of infected neurons in the PVN
observed 72 h following inoculation of the stomach with PRV-91,
PRV-25, PRV-26, and PRV-Bartha (Ba) are illustrated. Positive images,
where viral immunoreactivity in individual neurons is detected as a
black signal on a light background, are shown. Animals infected with
PRV-Becker (Be) did not survive beyond 67 h in this study and
could not be analyzed at this time after infection. All of the mutants
infect a substantial number of neurons in the medial parvicellular
subdivision of the PVN (mpPVN) as well as scattered neurons in the
dorsal parvicellular subdivision (dpPVN). Both of these cell groups
give rise to descending projections to autonomic nuclei in the brain
stem and spinal cord. The schematic diagram illustrates the
subdivisions of this hypothalamic nucleus. Calibration bar = 200 mm.
|
|

View larger version (114K):
[in this window]
[in a new window]
|
FIG. 7.
The distributions of infected neurons in the PVN
observed 96 h following inoculation of the stomach with PRV-91,
PRV-25, PRV-26, and PRV-Bartha (Ba) are illustrated. Positive images,
where viral immunoreactivity in individual neurons is detected as a
black signal on a light background, are shown. Animals infected with
PRV-Becker (Be) did not survive beyond 67 h in this study and
could not be analyzed at this late time after infection. All of the
mutants infect large numbers of neurons throughout the medial and
dorsal parvicellular subdivisions of the nucleus (mpPVN and dpPVN,
respectively) at this postinoculation interval. The schematic diagram
illustrates the subdivisions of this hypothalamic nucleus. Calibration
bar = 200 mm.
|
|
The extents of progression of retrograde transsynaptic infection
differ among gE mutants.
Distinct differences in the extents of
retrograde transsynaptic infection were observed in animals infected
with the gE mutants. As noted previously, the most-extensive infection
was observed in animals infected with PRV-Bartha, while the other gE
mutants infected a significant subset of that circuitry. Examination of the entire caudal brain stem and forebrain suggested that deletion of
gE (as in PRV-91) produced a more restricted pattern of infection than
those produced by mutants that expressed only the ectodomain of gE
(PRV-25 and PRV-26). This is particularly evident in comparing the
extents of infection in the PT and ventrolateral medulla. In these
areas, animals infected with PRV-25 or PRV-26 showed a robust
retrograde transsynaptic infection of neurons that approached that
produced by PRV-Bartha, whereas PRV-91 infected a smaller subset of
these neurons at the same postinoculation intervals (Fig. 2).
Similarly, fewer forebrain neurons were infected by PRV-91 than by
either of the mutants with carboxy-terminal deletions. Thus, the
extent of retrograde, transsynaptic infection by mutants that express
the N-terminal ectodomain of gE appears to be greater than
that produced by mutants in which the entire gE glycoprotein gene
has been deleted.
 |
DISCUSSION |
Many groups have shown that PRV encodes a variety of gene products
that promote virulence, i.e., the ability to cause disease (35). Operationally, such genes can be essential or
nonessential for growth in tissue culture cells and are usually defined
by mutations that reduce or abrogate the ability of a virus to cause disease. These mutations affect genes that fall into the following four
general classes: (i) genes whose products affect virus replication (e.g., thymidine kinase mutations or any mutation that reduces yield of
infectious virions), (ii) genes whose products are involved in movement
of virus in the host away from the site of initial infection (e.g.,
genes promoting cell-to-cell spread of virus or neuroinvasion genes),
(iii) genes that defeat host defenses (by producing complement binding
proteins, like gC, Fc receptors, like gE/gI, or proteins that reduce
major histocompatibility class I expression), and (iv) genes whose
products cause pathogenic effects on their own (toxins or intrinsic
virulence factors). The multifunctional gE gene product is a virulence
factor that, under certain circumstances, may affect at least three of
these four functions in promoting virulence, e.g., classes ii,
iii, and iv. In this study, we extend our previous work indicating that
gE expression promotes early virulence (rapid appearance of symptoms
and death) independently of its role in cell-to-cell spread
(46). Moreover, we demonstrate that the expression of early
virulence requires the cytoplasmic domain of the gE protein.
The multifunctional actions of gE in promoting virulence and spread
have been deduced from several lines of experimentation. First, it is
well known that gE is required for efficient cell-to-cell spread after
primary infection of epithelial cells (16, 20). Without this
function of gE, it is likely that a primary infection will be poorly
established because virus will not spread well among epithelial
cells at the primary site. Consequently, infections by gE mutants are
expected to be cleared rapidly by host innate defenses (e.g.,
interferons, NK cells, and complement) (20). It is likely
that lack of the gE-mediated, cell spread function in epithelial cells
is a primary reason for the attenuation of gE-deleted viruses in the
wide variety of animals susceptible to infection by PRV. Second, gE is
required for directional spread of virus infection in peripheral and
central neurons (18). This is a neuroinvasive function of gE
required for anterograde transneuronal transfer (passage from
presynaptic neurons to postsynaptic neurons) of virus in many neurons.
In pigs, gE and gI are required for PRV to spread to the olfactory bulb
after infection of the nasal olfactory mucosa, and in pigs and rodents,
it is required for transganglionic infection of trigeminal sensory
nuclei in the brain stem through the fifth (trigeminal) cranial
nerve (1, 26, 27). In rodents, a heterooligomer of gE
and/or gI is thought to be required for anterograde transsynaptic
infection of the optic tectum and lateral geniculate but not for
infection of neurons in CNS nuclei involved in the control of
circadian function (12, 13, 19, 48). Similarly,
in the rodent CNS, gE and gI are required, at least in part, for
anterograde transneuronal infection of the striatum after injection
into the prefrontal cortex (7). This directional
spread-and-release function of gE also may be required for spread
of newly produced virus to the mucosal surface after reactivation
from latency in sensory and autonomic neurons, rather than spread to
the CNS. A critical point is that gE is not required for retrograde
transsynaptic infection (passage from postsynaptic neurons to
presynaptic neurons) (18). Finally, gE expression results in
rapid appearance of symptoms and early death of infected animals
(18, 46). In this report, we demonstrate that this last
function is independent of the cell-to-cell spread and neuroinvasive
functions of the virus.
The circuit described in the present analysis has been used to define
the invasiveness of PRV and the specificity of transsynaptic passage of
virus (10, 11, 41). Its value lies in providing the
knowledge of the precise anatomical locations of multiple neuronal
groups involved in the circuit that enables one to discern the time
course and direction of infection through a complicated chain of
neurons. Another critical point is that virions injected into the
stomach wall are taken up at axon terminals by neurons and transported
to cell bodies that lie in the caudal brain stem. Thus, virus enters
the brain without any requirement for replication in the periphery. As
gE mutants have defects that reduce spread in epithelial cells and
affect anterograde spread in neurons, this model allows us to bypass
such potential complications and enables us to study gE functions
directly in CNS neurons. Early studies that compared the invasiveness
of PRV-Becker and PRV-Bartha in this circuitry demonstrated that the
primary neurons were first infected by PRV-Becker approximately 20 h earlier than by PRV-Bartha (10, 11, 41). The present data
confirm and extend those observations to encompass the role of the gE
protein, and more specifically the ectodomain of the protein, in this
transsynaptic spread. These data demonstrated that differences in
the extents of retrograde transneuronal spread of virus infection
produced by the gE mutants correlated with the type of mutation. Total elimination of the gE gene (as in PRV-91) resulted in extensive retrograde spread with a more restricted pattern of infection in
second- and third-order neurons than observed for PRV mutants that
encoded to varying degrees the N-terminal portion of the gE
glycoprotein. Therefore, the ectodomain of the gE protein permitted more extensive retrograde spread of virus through neural circuits. However, the most-extensive retrograde infection of the vagal autonomic circuitry was produced by PRV-Bartha, which harbors a number
of additional mutations.
All of the PRV gE mutants exhibited a marked decrease in virulence that
did not correlate with the magnitude of neuroinvasiveness. The
reduction in virulence occurred in spite of extensive retrograde transsynaptic passage of virus through the vagus autonomic circuitry, involving multiple areas in the brain stem and forebrain. We had noted
previously in our studies of the neuroinvasiveness of these mutants in
the rodent visual system a similar reduction in virulence and also
demonstrated that this reduction was directly related to the
elimination of the cytoplasmic domain of gE (46). It must be
noted that in the visual circuitry, the primary route of CNS invasion
is by anterograde spread. Importantly, those studies also revealed that
mutation of the gE gene did not compromise the neuroinvasiveness of PRV
in visual projections to regions in the brain involved in circadian
function (46). Taken together, these observations strongly
support the conclusion that virulence and neuroinvasiveness are
separate functions subserved by different portions of the gE
glycoprotein. While the N-terminal ectodomain of the protein is
sufficient to mediate anterograde transneuronal spread of the virus,
the C-terminal cytoplasmic domain of gE is required for full expression
of early virulence. This observation is the basis for our assertion
that the gene that encodes gE is a multifunctional virulence gene: it
is involved both in direct cell-to-cell spread among epithelial cells
and in directional spread between synaptically linked neurons, and it
also promotes symptoms and rapid death of infected animals. The
mechanism of gE-induced virulence subserved by the cytoplasmic domain
currently is under investigation.
 |
ACKNOWLEDGMENTS |
We gratefully acknowledge the expert technical assistance of
Marlies Eldridge. Members of the Enquist lab provided support and
constructive criticism.
This work was supported by NIH RO1s MH53574 (J.P.C.), NINDS33506
(L.W.E.), NIH grant 5T32GM07388 (R.S.T.), and GM27739 (R.R.M.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 314 Schultz
Laboratory, Department of Molecular Biology, Princeton University,
Princeton, NJ 08544. Phone: (609) 258-2415. Fax: (609) 258-1035. E-mail: Lenquist{at}molbio.princeton.edu.
 |
REFERENCES |
| 1.
|
Babic, N.,
B. Klupp,
A. Brack,
T. C. Mettenleiter,
G. Ugolini, and A. Flamand.
1996.
Deletion of glycoprotein gE reduces the propagation of pseudorabies virus in the nervous system of mice after intranasal inoculation.
Virology
219:279-284[Medline].
|
| 2.
|
Bains, J. S., and A. V. Ferguson.
1995.
Paraventricular nucleus neurons projecting to the spinal cord receive excitatory input from the subfornical organ.
Am. J. Physiol.
268:R625-R633[Abstract/Free Full Text].
|
| 3.
|
Balan, P.,
N. Davis-Poynter,
S. Bell,
H. Atkinson,
H. Browne, and T. Minson.
1994.
An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ.
J. Gen. Virol.
75:1245-1258[Abstract/Free Full Text].
|
| 4.
|
Banfield, B. W.,
G. S. Yap,
A. C. Knapp, and L. W. Enquist.
1998.
A chicken embryo eye model for the analysis of alphaherpesvirus neuronal spread and virulence.
J. Virol.
72:4580-4588[Abstract/Free Full Text].
|
| 5.
|
Bartha, A.
1961.
Experimental reduction of virulence of Aujeszky's disease virus.
Magy. Allatorv. Lapja
16:42-45.
|
| 6.
|
Ben-Porat, T.,
J. DeMarchi,
J. Pendrys,
R. A. Veach, and A. S. Kaplan.
1986.
Proteins specified by the short unique region of the genome of pseudorabies virus play a role in the release of virions from certain cells.
J. Virol.
57:191-196[Abstract/Free Full Text].
|
| 7.
|
Card, J. P.,
P. Levitt, and L. W. Enquist.
1998.
Different patterns of neuronal infection after intracerebral injection of two strains of pseudorabies virus.
J. Virol.
72:4434-4441[Abstract/Free Full Text].
|
| 8.
|
Card, J. P., and L. W. Enquist.
1994.
Use of pseudorabies virus for definition of synaptically linked populations of neurons.
Methods Mol. Genet.
4:363-382.
|
| 9.
|
Card, J. P.,
J. R. Dubin,
M. E. Whealy, and L. W. Enquist.
1995.
Influence of infectious dose upon productive replication and transsynaptic passage of pseudorabies virus in rat central nervous system.
J. Neurovirol.
1:349-358[Medline].
|
| 10.
|
Card, J. P.,
L. Rinaman,
R. B. Lynn,
B. H. Lee,
R. P. Meade,
R. R. Miselis, and L. W. Enquist.
1993.
Pseudorabies virus infection of the rat central nervous system: ultrastructural characterization of viral replication, transport, and pathogenesis.
J. Neurosci.
13:2515-2539[Abstract].
|
| 11.
|
Card, J. P.,
L. Rinaman,
J. S. Schwaber,
R. R. Miselis,
M. E. Whealy,
A. K. Robbins, and L. W. Enquist.
1990.
Neurotropic properties of pseudorabies virus: uptake and transneuronal passage in the rat central nervous system.
J. Neurosci.
10:1974-1994[Abstract].
|
| 12.
|
Card, J. P.,
M. E. Whealy,
A. K. Robbins, and L. W. Enquist.
1992.
Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system.
J. Virol.
66:3032-3041[Abstract/Free Full Text].
|
| 13.
|
Card, J. P.,
M. E. Whealy,
A. K. Robbins,
R. Y. Moore, and L. W. Enquist.
1991.
Two alpha-herpesvirus strains are transported differentially in the rodent visual system.
Neuron
6:957-969[Medline].
|
| 14.
|
de Wind, N.,
F. Wagenaar,
J. Pol,
T. Kimman, and A. Berns.
1992.
The pseudorabies virus homolog of the herpes simplex virus UL21 gene product is a capsid protein which is involved in capsid maturation.
J. Virol.
66:7096-7103[Abstract/Free Full Text].
|
| 15.
|
Dijkstra, J. M.,
T. C. Mettenleiter, and B. G. Klupp.
1997.
Intracellular processing of pseudorabies virus glycoprotein M (gM): gM of strain Bartha lacks N-glycosylation.
Virology
237:113-122[Medline].
|
| 16.
|
Dingwell, K. S.,
C. R. Brunetti,
R. L. Hendricks,
Q. Tang,
M. Tang,
A. J. Rainbow, and D. C. Johnson.
1994.
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells.
J. Virol.
68:834-845[Abstract/Free Full Text].
|
| 17.
|
Dingwell, K. S.,
L. C. Doering, and D. C. Johnson.
1995.
Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus.
J. Virol.
69:7087-7098[Abstract].
|
| 18.
|
Enquist, L. W.,
P. J. Husak,
B. W. Banfield, and G. A. Smith.
1999.
Infection and spread of alphaherpesviruses in the nervous system.
Adv. Virus Res.
51:237-347.
|
| 19.
|
Enquist, L. W.,
R. R. Miselis, and J. P. Card.
1994.
Specific infection of rat neuronal circuits by pseudorabies virus.
Gene Ther.
1:S10.
|
| 20.
|
Jacobs, L.
1994.
Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae.
Arch. Virol.
137:209-228[Medline].
|
| 21.
|
Jacobs, L.,
W. A. Mulder,
J. T. Van Oirschot,
A. L. Gielkens, and T. G. Kimman.
1993.
Deleting two amino acids in glycoprotein gI of pseudorabies virus decreases virulence and neurotropism for pigs, but does not affect immunogenicity.
J. Gen. Virol.
74:2201-2206[Abstract/Free Full Text].
|
| 22.
|
Jacobs, L.,
H. J. Rziha,
T. G. Kimman,
A. L. Gielkens, and J. T. Van Oirschot.
1993.
Deleting valine-125 and cysteine-126 in glycoprotein gI of pseudorabies virus strain NIA-3 decreases plaque size and reduces virulence in mice.
Arch. Virol.
131:251-264[Medline].
|
| 23.
|
Klupp, B. G.,
H. Kern, and T. C. Mettenleiter.
1992.
The virulence-determining genomic BamHI fragment 4 of pseudorabies virus contains genes corresponding to the UL15 (partial), UL18, UL19, UL20, and UL21 genes of herpes simplex virus and a putative origin of replication.
Virology
191:900-908[Medline].
|
| 24.
|
Klupp, B. G.,
B. Lomniczi,
N. Visser,
W. Fuchs, and T. C. Mettenleiter.
1995.
Mutations affecting the UL21 gene contribute to avirulence of pseudorabies virus vaccine strain Bartha.
Virology
212:466-473[Medline].
|
| 25.
|
Kovacs, F., and T. C. Mettenleiter.
1991.
Firefly luciferase as a marker for herpesvirus (pseudorabies virus) replication in vitro and in vivo.
J. Gen. Virol.
72:2999-3008[Abstract/Free Full Text].
|
| 26.
|
Kritas, S. K.,
H. J. Nauwynck, and M. B. Pensaert.
1995.
Dissemination of wild-type and gC-, gE- and gI-deleted mutants of Aujeszky's disease virus in the maxillary nerve and trigeminal ganglion of pigs after intranasal inoculation.
J. Gen. Virol.
76:2063-2066[Abstract/Free Full Text].
|
| 27.
|
Kritas, S. K.,
M. B. Pensaert, and T. C. Mettenleiter.
1994.
Role of envelope glycoproteins gI, gp63 and gIII in the invasion and spread of Aujeszky's disease virus in the olfactory nervous pathway of the pig.
J. Gen. Virol.
75:2319-2327[Abstract/Free Full Text].
|
| 28.
|
Li, Z., and A. V. Gerguson.
1993.
Subfornical organ efferents to paraventricular nucleus utilize angiotensin as a neurotransmitter.
Am. J. Physiol.
265:R302-R309[Abstract/Free Full Text].
|
| 29.
|
Loewy, A. D.
1995.
Pseudorabies virus: a transneuronal tracer for neuroanatomical studies, p. 349-366.
In
M. G. Knipe, and A. D. Loewy (ed.), Viral vectors. Gene therapy and neuroscience applications. Academic Press, Inc., San Diego, Calif.
|
| 30.
|
Lomniczi, B.,
M. L. Blankenship, and T. Ben-Porat.
1984.
Deletions in the genomes of pseudorabies virus vaccine strains and existence of four isomers of the genomes.
J. Virol.
49:970-979[Abstract/Free Full Text].
|
| 31.
|
Lomniczi, B.,
S. Watanabe,
T. Ben-Porat, and A. S. Kaplan.
1984.
Genetic basis of the neurovirulence of pseudorabies virus.
J. Virol.
52:198-205[Abstract/Free Full Text].
|
| 32.
|
Lomniczi, B.,
S. Watanabe,
T. Ben-Porat, and A. S. Kaplan.
1987.
Genome location and identification of functions defective in the Bartha vaccine strain of pseudorabies virus.
J. Virol.
61:796-801[Abstract/Free Full Text].
|
| 33.
|
Mallory, S.,
M. Sommer, and A. M. Arvin.
1997.
Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking.
J. Virol.
71:8279-8288[Abstract].
|
| 34.
|
McGeoch, D. J.
1990.
Evolutionary relationships of virion glycoprotein genes in the S regions of alphaherpesvirus genomes.
J. Gen. Virol.
71:2361-2367[Abstract/Free Full Text].
|
| 35.
|
Mettenleiter, T. C.
1994.
Pseudorabies (Aujeszk's disease) virus: state of the art.
Acta Vet. Hung.
42:153-177[Medline].
|
| 36.
|
Mettenleiter, T. C.,
B. Lomniczi,
N. Sugg,
C. Schreurs, and T. Ben-Porat.
1988.
Host cell-specific growth advantage of pseudorabies virus with a deletion in the genome sequences encoding a structural glycoprotein.
J. Virol.
62:12-19[Abstract/Free Full Text].
|
| 37.
|
Mettenleiter, T. C.,
C. Schreurs,
F. Zuckermann, and T. Ben-Porat.
1987.
Role of pseudorabies virus glycoprotein gI in virus release from infected cells.
J. Virol.
61:2764-2769[Abstract/Free Full Text].
|
| 38.
|
Mettenleiter, T. C.,
L. Zsak,
A. S. Kaplan,
T. Ben-Porat, and B. Lomniczi.
1987.
Role of a structural glycoprotein of pseudorabies in virus virulence.
J. Virol.
61:4030-4032[Abstract/Free Full Text].
|
| 39.
|
Miselis, R. R.
1981.
The efferent projections of the subfornical organ of the rat: a circumventricular organ within a neural circuitry subserving water balance.
Brain Res.
230:1-23[Medline].
|
| 40.
|
Rajcani, J.,
U. Herget, and H. C. Kaerner.
1990.
Spread of herpes simplex virus (HSV) strains SC16, ANG, ANGpath and its glyC minus and GlyE minus mutants in DBA-2 mice.
Acta Virol.
34:305-320[Medline].
|
| 41.
|
Rinaman, L.,
J. P. Card, and L. W. Enquist.
1993.
Spatiotemporal responses of astrocytes, ramified microglia, and brain macrophages to central neuronal infection with pseudorabies virus.
J. Neurosci.
13:685-702[Abstract].
|
| 42.
|
Robbins, A. K.,
J. P. Ryan,
M. E. Whealy, and L. W. Enquist.
1989.
The gene encoding the gIII envelope protein of pseudorabies virus vaccine strain Bartha contains a mutation affecting protein localization.
J. Virol.
63:250-258[Abstract/Free Full Text].
|
| 43.
|
Shioya, M., and J. Tanaka.
1989.
Inputs from the nucleus of the solitary tract to subfornical organ neurons projecting to the paraventricular nucleus in the rat.
Brain Res.
483:192-195[Medline].
|
| 44.
|
Strick, P. L., and J. P. Card.
1992.
Transneuronal mapping of neural circuits with alphaherpesviruses, p. 81-101.
In
J. P. Bolam (ed.), Experimental neuroanatomy. A practical approach. IRL Press, Oxford, United Kingdom.
|
| 45.
|
Tirabassi, R. S., and L. W. Enquist.
1999.
Mutation of the YXXL endocytosis motif in the cytoplasmic tail of pseudorabies virus gE.
J. Virol.
73:2717-2728[Abstract/Free Full Text].
|
| 46.
|
Tirabassi, R. S.,
R. A. Townley,
M. G. Eldridge, and L. W. Enquist.
1997.
Characterization of pseudorabies virus mutants expressing carboxy-terminal truncations of gE: evidence for envelope incorporation, virulence, and neurotropism domains.
J. Virol.
71:6455-6464[Abstract].
|
| 47.
|
Ugolini, G.
1995.
Transneuronal tracing with alpha-herpesviruses: a review of the methodology, p. 293-317.
In
M. G. Kaplitt, and A. D. Loewy (ed.), Viral vectors: gene therapy and neuroscience applications. Academic Press, Inc., San Diego, Calif.
|
| 48.
|
Whealy, M. E.,
J. P. Card,
A. K. Robbins,
J. R. Dubin,
H. J. Rziha, and L. W. Enquist.
1993.
Specific pseudorabies virus infection of the rat visual system requires both gI and gp63 glycoproteins.
J. Virol.
67:3786-3797[Abstract/Free Full Text].
|
| 49.
|
Zsak, L.,
T. C. Mettenleiter,
N. Sugg, and T. Ben-Porat.
1989.
Release of pseudorabies virus from infected cells is controlled by several viral functions and is modulated by cellular components.
J. Virol.
63:5475-5477[Abstract/Free Full Text].
|
| 50.
|
Zsak, L.,
N. Sugg, and T. Ben-Porat.
1992.
The different interactions of a gIII mutant of pseudorabies virus with several different cell types.
J. Gen. Virol.
73:821-827[Abstract/Free Full Text].
|
| 51.
|
Zsak, L.,
F. Zuckermann,
N. Sugg, and T. Ben-Porat.
1992.
Glycoprotein gI of pseudorabies virus promotes cell fusion and virus spread via direct cell-to-cell transmission.
J. Virol.
66:2316-2325[Abstract/Free Full Text].
|
Journal of Virology, May 1999, p. 4350-4359, Vol. 73, No. 5
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Curanovic, D., Lyman, M. G., Bou-Abboud, C., Card, J. P., Enquist, L. W.
(2009). Repair of the UL21 Locus in Pseudorabies Virus Bartha Enhances the Kinetics of Retrograde, Transneuronal Infection In Vitro and In Vivo. J. Virol.
83: 1173-1183
[Abstract]
[Full Text]
-
Olsen, L. M., Ch'ng, T. H., Card, J. P., Enquist, L. W.
(2006). Role of Pseudorabies Virus Us3 Protein Kinase during Neuronal Infection.. J. Virol.
80: 6387-6398
[Abstract]
[Full Text]
-
Paulus, C., Sollars, P. J., Pickard, G. E., Enquist, L. W.
(2006). Transcriptome Signature of Virulent and Attenuated Pseudorabies Virus-Infected Rodent Brain. J. Virol.
80: 1773-1786
[Abstract]
[Full Text]
-
Pomeranz, L. E., Reynolds, A. E., Hengartner, C. J.
(2005). Molecular Biology of Pseudorabies Virus: Impact on Neurovirology and Veterinary Medicine. Microbiol. Mol. Biol. Rev.
69: 462-500
[Abstract]
[Full Text]
-
Ch'ng, T. H., Enquist, L.W.
(2005). Neuron-to-Cell Spread of Pseudorabies Virus in a Compartmented Neuronal Culture System. J. Virol.
79: 10875-10889
[Abstract]
[Full Text]
-
Brittle, E. E., Reynolds, A. E., Enquist, L. W.
(2004). Two Modes of Pseudorabies Virus Neuroinvasion and Lethality in Mice. J. Virol.
78: 12951-12963
[Abstract]
[Full Text]
-
Rinaman, L., Schwartz, G.
(2004). Anterograde Transneuronal Viral Tracing of Central Viscerosensory Pathways in Rats. J. Neurosci.
24: 2782-2786
[Abstract]
[Full Text]
-
Klopfleisch, R., Teifke, J. P., Fuchs, W., Kopp, M., Klupp, B. G., Mettenleiter, T. C.
(2004). Influence of Tegument Proteins of Pseudorabies Virus on Neuroinvasion and Transneuronal Spread in the Nervous System of Adult Mice after Intranasal Inoculation. J. Virol.
78: 2956-2966
[Abstract]
[Full Text]
-
Flamand, A., Bennardo, T., Babic, N., Klupp, B. G., Mettenleiter, T. C.
(2001). The Absence of Glycoprotein gL, but Not gC or gK, Severely Impairs Pseudorabies Virus Neuroinvasiveness. J. Virol.
75: 11137-11145
[Abstract]
[Full Text]
-
DeFalco, J., Tomishima, M., Liu, H., Zhao, C., Cai, X., Marth, J. D., Enquist, L., Friedman, J. M.
(2001). Virus-Assisted Mapping of Neural Inputs to a Feeding Center in the Hypothalamus. Science
291: 2608-2613
[Abstract]
[Full Text]
-
Tirabassi, R. S., Enquist, L. W.
(2000). Role of the Pseudorabies Virus gI Cytoplasmic Domain in Neuroinvasion, Virulence, and Posttranslational N-Linked Glycosylation. J. Virol.
74: 3505-3516
[Abstract]
[Full Text]
-
Rinaman, L., Levitt, P., Card, J. P.
(2000). Progressive Postnatal Assembly of Limbic-Autonomic Circuits Revealed by Central Transneuronal Transport of Pseudorabies Virus. J. Neurosci.
20: 2731-2741
[Abstract]
[Full Text]
-
Kim, J.-S., Enquist, L. W., Card, J. P.
(1999). Circuit-Specific Coinfection of Neurons in the Rat Central Nervous System with Two Pseudorabies Virus Recombinants. J. Virol.
73: 9521-9531
[Abstract]
[Full Text]
-
Tomishima, M.J., Enquist, L.W.
(2001). A conserved {alpha}-herpesvirus protein necessary for axonal localization of viral membrane proteins. JCB
154: 741-752
[Abstract]
[Full Text]